Who Paid My Doc
Joyce Sherman
Livingston, NJ Medical Doctor
CMS profile 4225688
200 S Orange Ave, Livingston, NJ 07039
General payments
$814,546
Research payments
$826,836
Ownership & investment interest
$0
Research they led as principal investigator
$365,185
Through program year 2025, Joyce Sherman of Livingston, NJ is reported in the CMS Open Payments database as having received $814,546 across 502 general payments and $826,836 in research payments paid to them. Separately, studies naming them as principal investigator received $365,185 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
By program year
9 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $75 | 1 | |
| 2025 | Research | $118,545 | 17 | |
| 2024 | Research | $44,900 | 14 | |
| 2023 | Research | $325,642 | 16 | |
| 2022 | Research | $165,232 | 13 | |
| 2021 | General | $421,678 | 204 | |
| 2021 | Research | $172,518 | 12 | |
| 2020 | General | $327,521 | 190 | |
| 2019 | General | $65,273 | 107 |
Beside peers
- Joyce Sherman
- New Jersey median
- Middle half of New Jersey
- National median
In program year 2025, general payments to Joyce Sherman were reported at $75. Among 31,834 New Jersey profiles paid that year, the median was $178 and the middle half received between $51 and $585.
Show as a table
| Year | Joyce Sherman | New Jersey median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $65,273 | $150 | $44–$542 | $163 |
| 2020 | $327,521 | $110 | $33–$349 | $114 |
| 2021 | $421,678 | $125 | $36–$419 | $132 |
| 2022 | $0 | $142 | $42–$480 | $149 |
| 2023 | $0 | $156 | $48–$510 | $160 |
| 2024 | $0 | $167 | $50–$562 | $164 |
| 2025 | $75 | $178 | $51–$585 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
574 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Related records
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.